Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Penumbra Inc chart...

About the Company

Penumbra, Inc. is a medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

Exchange

NYSE

$1B

Total Revenue

2K

Employees

$8B

Market Capitalization

105.07

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PEN News

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

18h ago, source:

Penumbra, Inc. (NYSE: PEN), the world's largest thrombectomy company, announced the U.S. Food and Drug Administration (FDA) ...

Penumbra Lightning Flash 2.0 CAVT System Cleared by FDA and Launched

13h ago, source: Endovascular Today

Penumbra, Inc. announced the FDA clearance and launch of Lightning Flash 2.0, the company’s next-generation computer assist ...

Here's Why You Should Retain Penumbra (PEN) Stock for Now

15d ago, source: Zacks.com on MSN

Penumbra, Inc. PEN is likely to grow in the coming quarters, backed by the strength exhibited in the Thrombectomy business. Immersive Healthcare business, too, is making significant progress. However, ...

Penumbra Inc

1mon ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

Penumbra, Inc. Common Stock (PEN)

6mon ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Are Penumbra, Inc.'s (NYSE:PEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

1mon ago, source: Yahoo Finance

It is hard to get excited after looking at Penumbra's (NYSE:PEN) recent performance, when its stock has declined 13% over the past month. But if you pay close attention, you might find that its ...

Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...

20d ago, source:

Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction ...

Penumbra Inc.

1y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...